SM
RCEL icon

SG3 Management’s Avita Medical RCEL Stock Holding History

SG3 Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,650
Closed -$156K – 309
2022
Q3 		$156K Sell
29,650
-2,350
-7% -$14.5K 0.02% 210
2022
Q2 		$152K Buy
32,000
+17,000
+113% +$105K 0.02% 299
2022
Q1 		$127K Buy
+15,000
New +$138K ﹤0.01% 819

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SG3 Management's RCEL Position: Q4 2022 in Review

SG3 Management sold out of Avita Medical (RCEL) in Q4 2022, closing a stake of 29,650 shares — an estimated $156K sold.

SG3 Management first reported a position in RCEL in Q1 2022 and held it in 3 quarters. The position peaked at $156K in Q3 2022. 52 funds tracked by Wall St. Rank hold RCEL as of Q4 2022.

  • SG3 Management reported no remaining Avita Medical position as of Q4 2022 after selling out during the quarter.
  • SG3 Management sold 29,650 Avita Medical shares in Q4 2022, an estimated $156K.
  • SG3 Management first reported a position in Avita Medical in Q1 2022 and held it in 3 quarters.
  • SG3 Management's Avita Medical position peaked at $156K in Q3 2022.
  • 52 funds tracked by Wall St. Rank held Avita Medical as of Q4 2022.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.